Press Release Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune Royalty Pharma plc · Jul 22
Press Release Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy Radiopharm Theranostics · Jul 22
Press Release Danantara Opens Lenders Panel for Indonesia Waste-to-Energy Financing Danantara Indonesia · Jul 22
Press Release SOLV Energy to Report Second Quarter 2026 Financial Results on August 13, 2026 SOLV Energy, Inc. · Jul 22
Press Release Fidelis Capital Welcomes Respected Equity Strategist Herb Achey as Partner Fidelis Capital Partners · Jul 22